Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                      1.2. Segment Definitions
                          1.2.1. Product
                          1.2.2. End-use
                          1.2.3. Regional scope
                          1.2.4. Estimates and forecasts timeline
                      1.3. Research Methodology
                      1.4. Information Procurement
                          1.4.1. Purchased database
                          1.4.2. GVR’s internal database
                          1.4.3. Secondary sources
                          1.4.4. Primary research
                          1.4.5. Details of primary research
                              1.4.5.1. Data for primary interviews in North America
                              1.4.5.2. Data for primary interviews in Europe
                              1.4.5.3. Data for primary interviews in Asia Pacific
                              1.4.5.4. Data for primary interviews in Latin America
                              1.4.5.5. Data for Primary interviews in MEA
                      1.5. Information or Data Analysis
                          1.5.1. Data analysis models
                      1.6. Market Formulation & Validation
                      1.7. Model Details
                          1.7.1. Commodity flow analysis (Model 1)
                          1.7.2. Approach 1: Commodity flow approach
                          1.7.3. Volume price analysis (Model 2)
                          1.7.4. Approach 2: Volume price analysis
                      1.8. List of Secondary Sources
                      1.9. List of Primary Sources
                      1.10. Objectives
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Product outlook
                          2.2.2. End-use outlook
                          2.2.3. Regional outlook
                      2.3. Competitive Insights
Chapter 3. Personalized Medicine Market Variables, Trends & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Market Dynamics
                          3.2.1. Market driver analysis
                              3.2.1.1. Advancements in next-generation sequencing technology
                              3.2.1.2. Expanding portfolio of companion/associated diagnostics
                              3.2.1.3. Increasing prevalence of cancer & usage of biomarkers for personalized medicine cancer therapy
                              3.2.1.4. Technological advancements to facilitate R&D for personalized medicine
                          3.2.2. Market restraint analysis
                              3.2.2.1. Presence of nonvalue-based personalized medicine diagnostics reimbursement policy
                              3.2.2.2. Lack of proper intellectual property regulations for personalized medical technologies
                      3.3. Personalized Medicine Market Analysis Tools
                          3.3.1. Industry Analysis - Porter’s
                              3.3.1.1. Supplier power
                              3.3.1.2. Buyer power
                              3.3.1.3. Substitution threat
                              3.3.1.4. Threat of new entrant
                              3.3.1.5. Competitive rivalry
                          3.3.2. PESTEL Analysis
                              3.3.2.1. Political landscape
                              3.3.2.2. Technological landscape
                              3.3.2.3. Economic landscape
Chapter 4. Personalized Medicine Market: Product Estimates & Trend Analysis
                      4.1. Product Market Share, 2023 & 2030
                      4.2. Segment Dashboard
                      4.3. Global Personalized Medicine Market by Product Outlook
                      4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                          4.4.1. Personalized Medicine Diagnostics
                              4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.1.2. Genetic Testing
                                  4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.1.3. DTC Diagnostics
                                  4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.1.4. Esoteric Lab Services
                                  4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.1.5. Esoteric Lab Tests
                                  4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.4.2. Personalized Medicine Therapeutics
                              4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.2.2. Pharmaceutical
                                  4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.2.3. Genomic Medicine
                                  4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.2.4. Medical Devices
                                  4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.4.3. Personalized Medical Care
                              4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.3.2. Telemedicine
                                  4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.3.3. Health Information Technology
                                  4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.4.4. Personalized Nutrition & Wellness
                              4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.4.2. Retail Nutrition
                                  4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.4.3. Complementary & Alternative Medicine
                                  4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. Personalized Medicine Market: End-use Estimates & Trend Analysis
                      5.1. Method Market Share, 2023 & 2030
                      5.2. Segment Dashboard
                      5.3. Global Personalized Medicine Market by End-use Outlook
                      5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                          5.4.1. Hospitals
                              5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          5.4.2. Academic & Research Institutes
                              5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          5.4.3. Diagnostic Centers
                              5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          5.4.4. Others
                              5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. Personalized Medicine Market: Regional Estimates & Trend Analysis
                      6.1. Regional Market Share Analysis, 2023 & 2030
                      6.2. Regional Market Dashboard
                      6.3. Global Regional Market Snapshot
                      6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                      6.5. North America
                          6.5.1. U.S.
                              6.5.1.1. Key country dynamics
                              6.5.1.2. Regulatory framework/ reimbursement structure
                              6.5.1.3. Competitive scenario
                              6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.5.2. Canada
                              6.5.2.1. Key country dynamics
                              6.5.2.2. Regulatory framework/ reimbursement structure
                              6.5.2.3. Competitive scenario
                              6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
                      6.6. Europe
                          6.6.1. UK
                              6.6.1.1. Key country dynamics
                              6.6.1.2. Regulatory framework/ reimbursement structure
                              6.6.1.3. Competitive scenario
                              6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.6.2. Germany
                              6.6.2.1. Key country dynamics
                              6.6.2.2. Regulatory framework/ reimbursement structure
                              6.6.2.3. Competitive scenario
                              6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.6.3. France
                              6.6.3.1. Key country dynamics
                              6.6.3.2. Regulatory framework/ reimbursement structure
                              6.6.3.3. Competitive scenario
                              6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.6.4. Italy
                              6.6.4.1. Key country dynamics
                              6.6.4.2. Regulatory framework/ reimbursement structure
                              6.6.4.3. Competitive scenario
                              6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.6.5. Spain
                              6.6.5.1. Key country dynamics
                              6.6.5.2. Regulatory framework/ reimbursement structure
                              6.6.5.3. Competitive scenario
                              6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.6.6. Norway
                              6.6.6.1. Key country dynamics
                              6.6.6.2. Regulatory framework/ reimbursement structure
                              6.6.6.3. Competitive scenario
                              6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.6.7. Sweden
                              6.6.7.1. Key country dynamics
                              6.6.7.2. Regulatory framework/ reimbursement structure
                              6.6.7.3. Competitive scenario
                              6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.6.8. Denmark
                              6.6.8.1. Key country dynamics
                              6.6.8.2. Regulatory framework/ reimbursement structure
                              6.6.8.3. Competitive scenario
                              6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
                      6.7. Asia Pacific
                          6.7.1. Japan
                              6.7.1.1. Key country dynamics
                              6.7.1.2. Regulatory framework/ reimbursement structure
                              6.7.1.3. Competitive scenario
                              6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.7.2. China
                              6.7.2.1. Key country dynamics
                              6.7.2.2. Regulatory framework/ reimbursement structure
                              6.7.2.3. Competitive scenario
                              6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.7.3. India
                              6.7.3.1. Key country dynamics
                              6.7.3.2. Regulatory framework/ reimbursement structure
                              6.7.3.3. Competitive scenario
                              6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.7.4. Australia
                              6.7.4.1. Key country dynamics
                              6.7.4.2. Regulatory framework/ reimbursement structure
                              6.7.4.3. Competitive scenario
                              6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.7.5. South Korea
                              6.7.5.1. Key country dynamics
                              6.7.5.2. Regulatory framework/ reimbursement structure
                              6.7.5.3. Competitive scenario
                              6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.7.6. Thailand
                              6.7.6.1. Key country dynamics
                              6.7.6.2. Regulatory framework/ reimbursement structure
                              6.7.6.3. Competitive scenario
                              6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
                      6.8. Latin America
                          6.8.1. Brazil
                              6.8.1.1. Key country dynamics
                              6.8.1.2. Regulatory framework/ reimbursement structure
                              6.8.1.3. Competitive scenario
                              6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.8.2. Mexico
                              6.8.2.1. Key country dynamics
                              6.8.2.2. Regulatory framework/ reimbursement structure
                              6.8.2.3. Competitive scenario
                              6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.8.3. Argentina
                              6.8.3.1. Key country dynamics
                              6.8.3.2. Regulatory framework/ reimbursement structure
                              6.8.3.3. Competitive scenario
                              6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
                      6.9. MEA
                          6.9.1. South Africa
                              6.9.1.1. Key country dynamics
                              6.9.1.2. Regulatory framework/ reimbursement structure
                              6.9.1.3. Competitive scenario
                              6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.9.2. Saudi Arabia
                              6.9.2.1. Key country dynamics
                              6.9.2.2. Regulatory framework/ reimbursement structure
                              6.9.2.3. Competitive scenario
                              6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.9.3. UAE
                              6.9.3.1. Key country dynamics
                              6.9.3.2. Regulatory framework/ reimbursement structure
                              6.9.3.3. Competitive scenario
                              6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
                          6.9.4. Kuwait
                              6.9.4.1. Key country dynamics
                              6.9.4.2. Regulatory framework/ reimbursement structure
                              6.9.4.3. Competitive scenario
                              6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 7. Competitive Landscape
                      7.1. Recent Developments & Impact Analysis, By Key Market Participants
                      7.2. Company/Competition Categorization
                      7.3. Vendor Landscape
                          7.3.1. List of key distributors and channel partners
                          7.3.2. Key customers
                          7.3.3. Key company market share analysis, 2023
                          7.3.4. GE Healthcare
                              7.3.4.1. Overview
                              7.3.4.2. Financial Performance
                              7.3.4.3. Product Benchmarking
                              7.3.4.4. Strategic Initiatives
                          7.3.5. Illumina, Inc.
                              7.3.5.1. Overview
                              7.3.5.2. Financial Performance
                              7.3.5.3. Product Benchmarking
                              7.3.5.4. Strategic Initiatives
                          7.3.6. ASURAGEN, INC.
                              7.3.6.1. Overview
                              7.3.6.2. Financial Performance
                              7.3.6.3. Product Benchmarking
                              7.3.6.4. Strategic Initiatives
                          7.3.7. Abbott
                              7.3.7.1. Overview
                              7.3.7.2. Financial Performance
                              7.3.7.3. Product Benchmarking
                              7.3.7.4. Strategic Initiatives
                          7.3.8. Dako A/S
                              7.3.8.1. Overview
                              7.3.8.2. Financial Performance
                              7.3.8.3. Product Benchmarking
                              7.3.8.4. Strategic Initiatives
                          7.3.9. Exact Sciences Corporation
                              7.3.9.1. Overview
                              7.3.9.2. Financial Performance
                              7.3.9.3. Product Benchmarking
                              7.3.9.4. Strategic Initiatives
                          7.3.10. Danaher Corporation (Cepheid, Inc.)
                              7.3.10.1. Overview
                              7.3.10.2. Financial Performance
                              7.3.10.3. Product Benchmarking
                              7.3.10.4. Strategic Initiatives
                          7.3.11. Decode Genetics, Inc.
                              7.3.11.1. Overview
                              7.3.11.2. Financial Performance
                              7.3.11.3. Product Benchmarking
                              7.3.11.4. Strategic Initiatives
                          7.3.12. QIAGEN
                              7.3.12.1. Overview
                              7.3.12.2. Financial Performance
                              7.3.12.3. Product Benchmarking
                              7.3.12.4. Strategic Initiatives
                          7.3.13. Exagen Inc.
                              7.3.13.1. Overview
                              7.3.13.2. Financial Performance
                              7.3.13.3. Product Benchmarking
                              7.3.13.4. Strategic Initiatives
                          7.3.14. Precision Biologics
                              7.3.14.1. Overview
                              7.3.14.2. Financial Performance
                              7.3.14.3. Product Benchmarking
                              7.3.14.4. Strategic Initiatives
                          7.3.15. Celera Diagnostics LLC
                              7.3.15.1. Overview
                              7.3.15.2. Financial Performance
                              7.3.15.3. Product Benchmarking
                              7.3.15.4. Strategic Initiatives
                          7.3.16. Biogen
                              7.3.16.1. Overview
                              7.3.16.2. Financial Performance
                              7.3.16.3. Product Benchmarking
                              7.3.16.4. Strategic Initiatives
                          7.3.17. Genelex
                              7.3.17.1. Overview
                              7.3.17.2. Financial Performance
                              7.3.17.3. Product Benchmarking
                              7.3.17.4. Strategic Initiatives
                          7.3.18. IBM
                              7.3.18.1. Overview
                              7.3.18.2. Financial Performance
                              7.3.18.3. Product Benchmarking
                              7.3.18.4. Strategic Initiatives
                          7.3.19. Genentech, Inc.
                              7.3.19.1. Overview
                              7.3.19.2. Financial Performance
                              7.3.19.3. Product Benchmarking
                              7.3.19.4. Strategic Initiatives
                          7.3.20. 23andMe, Inc.
                              7.3.20.1. Overview
                              7.3.20.2. Financial Performance
                              7.3.20.3. Product Benchmarking
                              7.3.20.4. Strategic Initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
Table 3 North America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 4 North America Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 5 U.S. Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 6 U.S. Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 7 Canada Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 8 Canada Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 9 Europe Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
Table 10 Europe Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 11 Europe Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 12 France Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 13 France Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 14 Germany Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 15 Germany Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 16 UK Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 17 UK Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 18 Spain Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 19 Spain Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 20 France Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 21 France Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 22 Italy Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 23 Italy Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 24 Sweden Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 25 Sweden Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 26 Norway Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 27 Norway Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 28 Denmark Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 29 Denmark Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 30 Asia Pacific Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
Table 31 Asia Pacific Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 32 Asia Pacific Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 33 Japan Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 34 Japan Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 35 China Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 36 China Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 37 India Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 38 India Personalized Medicine Market, By End-Use, 2018 - 2030 (USD Billion)
Table 39 South Korea Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 40 South Korea Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 41 Australia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 42 Australia Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 43 Thailand Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 44 Thailand Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 45 Latin America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
Table 46 Latin America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 47 Latin America Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 48 Brazil Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 49 Brazil Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 50 Mexico Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 51 Mexico Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 52 Argentina Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 53 Argentina Personalized Medicine Market, By End-Use, 2018 - 2030 (USD Billion)
Table 54 MEA Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
Table 55 MEA Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 56 MEA Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 57 South Africa Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 58 South Africa Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 59 Saudi Arabia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 60 Saudi Arabia Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 61 UAE Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 62 UAE Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)
Table 63 Kuwait Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
Table 64 Kuwait Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Personalized medicine market segmentation
Fig. 8 Market snapshot, 2023
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global personalized medicine market, for product, 2018 - 2030 (USD Billion)
Fig. 15 Global personalized medicine market, for diagnostics, 2018 - 2030 (USD Billion)
Fig. 16 Global personalized medicine market, for genetic testing, 2018 - 2030 (USD Billion)
Fig. 17 Global personalized medicine market, for direct-to-consumer (DTC) testing, 2018 - 2030 (USD Billion)
Fig. 18 Global personalized medicine market, for esoteric lab services, 2018 - 2030 (USD Billion)
Fig. 19 Global personalized medicine market, for esoteric lab tests, 2018 - 2030 (USD Billion)
Fig. 20 Global personalized medicine market, for therapeutics, 2018 - 2030 (USD Billion)
Fig. 21 Global personalized medicine market, for pharmaceutical, 2018 - 2030 (USD Billion)
Fig. 22 Global personalized medicine market, for genomic medicine, 2018 - 2030 (USD Billion)
Fig. 23 Global personalized medicine market, for medical devices, 2018 - 2030 (USD Billion)
Fig. 24 Global personalized medicine market, for personalized medical care, 2018 - 2030 (USD Billion)
Fig. 25 Global personalized medicine market, for telemedicine, 2018 - 2030 (USD Billion)
Fig. 26 Global personalized medicine market, for health information technology, 2018 - 2030 (USD Billion)
Fig. 27 Global personalized medicine market, for personalized nutrition & wellness, 2018 - 2030 (USD Billion)
Fig. 28 Global personalized medicine market, for retail nutrition, 2018 - 2030 (USD Billion)
Fig. 29 Global personalized medicine market, for complementary & alternative medicine, 2018 - 2030 (USD Billion)
Fig. 30 Global personalized medicine market, for End-use, 2018 - 2030 (USD Billion)
Fig. 31 Global personalized medicine market, for diagnostics centers, 2018 - 2030 (USD Billion)
Fig. 32 Global personalized medicine market, for academic and research institutes, 2018 - 2030 (USD Billion)
Fig. 33 Global personalized medicine market, for hospitals, 2018 - 2030 (USD Billion)
Fig. 34 Global personalized medicine market, for others, 2018 - 2030 (USD Billion)
Fig. 35 Regional outlook, 2023 & 2030
Fig. 36 North America personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 37 U.S. personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 38 Canada personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 39 Europe personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 40 Germany personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 41 UK personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 42 France personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 43 Italy personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 44 Spain personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 45 Denmark personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 46 Sweden personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 47 Norway personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 48 Asia Pacific personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 49 Japan personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 50 China personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 51 India personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 52 Australia personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 53 Thailand personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 54 South Korea personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 55 Latin America personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 56 Brazil personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 57 Mexico personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 58 Argentina personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 59 MEA personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 60 South Africa personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 61 Saudi Arabia personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 62 UAE personalized medicine market, 2018 - 2030 (USD Billion)
Fig. 63 Kuwait personalized medicine market, 2018 - 2030 (USD Billion)